96 related articles for article (PubMed ID: 25417701)
1. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
Kim HJ; Kim SH; Yu EJ; Seo WY; Kim JH
Oncogene; 2015 Aug; 34(34):4500-8. PubMed ID: 25417701
[TBL] [Abstract][Full Text] [Related]
2. Balance between SIRT1 and DBC1 expression is lost in breast cancer.
Sung JY; Kim R; Kim JE; Lee J
Cancer Sci; 2010 Jul; 101(7):1738-44. PubMed ID: 20412117
[TBL] [Abstract][Full Text] [Related]
3. Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.
Magni M; Ruscica V; Buscemi G; Kim JE; Nachimuthu BT; Fontanella E; Delia D; Zannini L
Nucleic Acids Res; 2014 Dec; 42(21):13150-60. PubMed ID: 25361978
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β.
Parija M; Prakash S; Krishna BM; Dash S; Mishra SK
Breast Cancer; 2024 May; 31(3):440-455. PubMed ID: 38421553
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory protein-protein interactions of the SIRT1 deacetylase are choreographed by post-translational modification.
Krzysiak TC; Choi YJ; Kim YJ; Yang Y; DeHaven C; Thompson L; Ponticelli R; Mermigos MM; Thomas L; Marquez A; Sipula I; Kemper JK; Jurczak M; Thomas G; Gronenborn AM
Protein Sci; 2024 Apr; 33(4):e4938. PubMed ID: 38533551
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity.
Kang JA; Kim YJ; Jang KY; Moon HW; Lee H; Lee S; Song HK; Cho SW; Yoo YS; Han HG; Kim MJ; Chung MJ; Choi CY; Lee C; Chung C; Hur GM; Kim YS; Jeon YJ
Exp Mol Med; 2024 Mar; 56(3):656-673. PubMed ID: 38443596
[TBL] [Abstract][Full Text] [Related]
7. DBC1 functions as a tumor suppressor by regulating p53 stability.
Qin B; Minter-Dykhouse K; Yu J; Zhang J; Liu T; Zhang H; Lee S; Kim J; Wang L; Lou Z
Cell Rep; 2015 Mar; 10(8):1324-34. PubMed ID: 25732823
[TBL] [Abstract][Full Text] [Related]
8. Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.
Yu EJ; Kim SH; Kim HJ; Heo K; Ou CY; Stallcup MR; Kim JH
Oncogene; 2016 Jun; 35(26):3410-8. PubMed ID: 26477307
[TBL] [Abstract][Full Text] [Related]
9. DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcoma.
Wagle S; Park SH; Kim KM; Moon YJ; Bae JS; Kwon KS; Park HS; Lee H; Moon WS; Kim JR; Jang KY
Sci Rep; 2015 Aug; 5():13144. PubMed ID: 26249023
[TBL] [Abstract][Full Text] [Related]
10. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells.
Mauro L; Pellegrino M; Giordano F; Ricchio E; Rizza P; De Amicis F; Catalano S; Bonofiglio D; Panno ML; Andò S
FASEB J; 2015 May; 29(5):2150-60. PubMed ID: 25657113
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation profiles and biomarkers of oral squamous cell carcinoma.
Li YF; Hsiao YH; Lai YH; Chen YC; Chen YJ; Chou JL; Chan MW; Lin YH; Tsou YA; Tsai MH; Tai CK
Epigenetics; 2015; 10(3):229-36. PubMed ID: 25612142
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses the proliferation of breast cancer cells by inhibiting fatty acid synthase signaling pathway.
Khan A; Aljarbou AN; Aldebasi YH; Faisal SM; Khan MA
Cancer Epidemiol; 2014 Dec; 38(6):765-72. PubMed ID: 25448084
[TBL] [Abstract][Full Text] [Related]
14. Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.
Qi T; Qu Q; Li G; Wang J; Zhu H; Yang Z; Sun Y; Lu Q; Qu J
Am J Cancer Res; 2020; 10(10):3083-3105. PubMed ID: 33163259
[TBL] [Abstract][Full Text] [Related]
15. ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.
Rodriguez AC; Vahrenkamp JM; Berrett KC; Clark KA; Guillen KP; Scherer SD; Yang CH; Welm BE; Janát-Amsbury MM; Graves BJ; Gertz J
Cancer Res; 2020 Mar; 80(6):1234-1245. PubMed ID: 32046982
[TBL] [Abstract][Full Text] [Related]
16. Capicua suppresses colorectal cancer progression via repression of ETV4 expression.
Lee JS; Kim E; Lee J; Kim D; Kim H; Kim CJ; Kim S; Jeong D; Lee Y
Cancer Cell Int; 2020; 20():42. PubMed ID: 32042269
[TBL] [Abstract][Full Text] [Related]
17. ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis.
Dumortier M; Ladam F; Damour I; Vacher S; Bièche I; Marchand N; de Launoit Y; Tulasne D; Chotteau-Lelièvre A
Breast Cancer Res; 2018 Jul; 20(1):73. PubMed ID: 29996935
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Receptor Signaling in Breast Cancer.
Miziak P; Baran M; Błaszczak E; Przybyszewska-Podstawka A; Kałafut J; Smok-Kalwat J; Dmoszyńska-Graniczka M; Kiełbus M; Stepulak A
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835383
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.
Kim HJ; Moon SJ; Kim JH
Exp Mol Med; 2023 Aug; 55(8):1691-1701. PubMed ID: 37524873
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in the Aging Microenvironment of Breast Cancer.
Jiang X; Shen H; Shang X; Fang J; Lu Y; Lu Y; Zheng J; Fu P
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
